Aera Therapeutics
PrivateLast Round
Series A
and B
Feb 16, 2023
Total Funding Raised
$193M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Aera Therapeutics is a biotechnology company that develops proprietary delivery platforms, including protein nanoparticles, lipid nanoparticles, and antibody-oligonucleotide conjugates, to enable transformative genetic medicines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aera Therapeutics Comparables
Compare Aera Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stylus Medicine | 89% | |
| Velvet Therapeutics | 85% | |
| Alaya.bio | 84% |
Aera Therapeutics Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
Aera Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GV | Series A and B |
| Lux Capital | Series A and B |
| ARCH Venture Partners | Series A and B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 33% MoM, reaching 4.8K.
- Dec 2, 2025
Presented data on AERA-109, a targeted In Vivo CAR-T therapy.
Aera Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Aera Therapeutics's valuation, stock price, and market status.
Is Aera Therapeutics a public or private company?
Aera Therapeutics is a private company.
What is the current stock price of Aera Therapeutics?
Aera Therapeutics is a private company, so its shares have no public market price. Caplight tracks Aera Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Aera Therapeutics worth (valuation)?
Valuation information for Aera Therapeutics is not publicly available.
Can I buy Aera Therapeutics stock?
Aera Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Aera Therapeutics's last funding round?
Aera Therapeutics's most recent funding round was Series A and B on February 16, 2023.
Who are the main investors in Aera Therapeutics?
Key investors in Aera Therapeutics include GV, Lux Capital, ARCH Venture Partners.
Will Aera Therapeutics IPO soon?
No public IPO plans have been announced for Aera Therapeutics.
How can I track Aera Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Aera Therapeutics's shares on secondary markets.